FILORGA was founded in 1978 by Michel Tordjman, a French doctor of aesthetic medicine, with a fascination for cellular biology.
Michel Tordjman pioneered NCTF® , New Cellular Treatment Factor, a unique injectable solution that prevents, slows and corrects the effects of skin ageing.
Dr Tordjman’s innovations were originally intended to provide dermatologists and doctors of aesthetic medicine with an extensive range of treatment solutions: peeling treatments, hyaluronic acid injections and mesotherapy.